Marc De Baets

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

Olaf Stüve, Petra D. Cravens, Elliot M. Frohman et al. · Neurology · 2008 · 130 citations · Full text

Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis

Sandrine Poëa‐Guyon, Premkumar Christadoss, Rozen Le Panse et al. · The Journal of Immunology · 2005 · 103 citations · Full text

Immunology, Immune Regulation, Cellular Physiology +17

Experimental Autoimmune Myasthenia Gravis May Occur in the Context of a Polarized Th1- or Th2-Type Immune Response in Rats

Abdelhadi Saoudi, I Bernard, Astrid Hoedemaekers et al. · The Journal of Immunology · 1999 · 82 citations

MuSK autoantibodies in myasthenia gravis detected by cell based assay — A multinational study

Anastasios Tsonis, Paraskevi Zisimopoulou, Konstantinos Lazaridis et al. · Journal of Neuroimmunology · 2015 · 79 citations · Full text

Autoimmune Disease, Musk Autoantibodies, Immunology +7